Urine colorimetry for therapeutic drug monitoring of pyrazinamide during tuberculosis treatment

The urine colorimetric assay was sensitive but not specific for the detection of adequate pyrazinamide pharmacokinetic exposures among HIV/tuberculosis patients in a high-burden setting.